Skip to content

4Accepted Dec 16, 5:00 PM ET

Bellinger Andrew 4

VERVVerve Therapeutics, Inc.

sec.gov(opens the filing on sec.gov)View full filing

Accepted (ET)

5:00 PM

Dec 16, 2022

Filed

Dec 16, 2022

Documents

1

Size

6.9 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.